Description
Release form
Tablets.
Packing
20 pcs.
Pharmacological action
Laripront – a combined preparation with antiviral, antimicrobial, antifungal, anti-inflammatory, hemostatic and mucolytic action for local application in ENT practice and dentistry.
Lysozyme – a natural enzyme (mucopolysaccharidase), forming a complex with viruses and preventing their entry into cells, has an antiviral effect. It has an antimicrobial effect against gram-positive and some gram-negative bacteria due to the destruction of the cell wall of microorganisms.
In addition, lysozyme has anti-inflammatory, hemostatic and mucolytic effects due to histamine blockade, inactivation of heparin and cleavage of mucopolysaccharides.
Dequalinium chloride is an antiseptic effective against gram-positive and gram-negative microorganisms, as well as fungi. With the ability to reduce surface tension, provides the penetration of active substances into deeper sections of the mucous membrane.
Indications
Bacterial and fungal infectious and inflammatory diseases of the oral cavity, pharynx and larynx (stomatitis, pharyngitis, laryngitis, tonsillitis, tonsillitis, thrush, etc.) before and after dental and ENT operations.
Contraindications
Hypersensitivity.
Composition
Active ingredient:
dequalinium chloride 0.25 mg (based on 100% activity)
lysozyme hydrochloride 11.00 mg (based on 100% activity, including 10% excess)
Excipients:
To 25 20.00 mg
magnesium stearate 15.00 mg
anise aromatic essence 89617 0.50 mg
peppermint aromatic essence 89664 3.00 mg
sucrose.
Dosage and administration
Laripront taken orally, 30 minutes before a meal, 1 tablet. (kept in the mouth or under the tongue until completely dissolved) every 2-3 hours
for 30 minutes after taking the pill should refrain from eating food or liquid.
Side effects
Allergic reactions.
Storage conditions
In the dark place at a temperature of no higher than 25 ° C.
Active ingredient
Dequalinium chloride, Lysozyme hydrochloride
The dosage form of
tablet
Henry Mack Heir, Germany
